No abstract available
MeSH terms
-
Age Factors
-
Aged
-
Aged, 80 and over
-
Antineoplastic Agents, Hormonal / therapeutic use*
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / surgery
-
Chemotherapy, Adjuvant*
-
Clinical Trials as Topic
-
Comorbidity
-
Cost-Benefit Analysis
-
Decision Making
-
Female
-
Humans
-
Patient Selection
-
Prognosis
-
Risk Factors
-
Survival Analysis
-
Tamoxifen / therapeutic use*
Substances
-
Antineoplastic Agents, Hormonal
-
Tamoxifen